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Abstract. Detection and enumeration of rare circulating cells in mice are important problems in many areas of
preclinical biomedical research. Recently, we developed a new method termed “diffuse fluorescence flow cytom-
etry” (DFFC) that uses diffuse photons to increase the blood sampling volume and sensitivity versus existing in vivo
flow cytometry methods. In this work, we describe a new DFFC prototype with approximately an order-of-magni-
tude improvement in sensitivity compared to our previous work. This sensitivity improvement is enabled by a num-
ber of technical innovations, which include a method for the removal of motion artifacts (allowing interrogation of
mouse hindlegs that was less optically attenuating versus the tail) and improved collection optics and signal pre-
amplification. We validated oursystem first in limb mimicking optical flow phantomswithfluorescent microspheres
and then in nude mice with fluorescently labeled mesenchymal stem cells at injected concentrations of
5 × 103 cells∕mL. In combination, these improvements resulted in an overall cell counting sensitivity of about
1 cell∕mL or better in vivo. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or
reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.18.7.077002]
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1 Introduction
Quantification of rare circulating cell populations in mice is
important in many areas of preclinical biomedical research
such as immunology, stem cell-based therapeutics, and the
metastatic spread of cancer.1–4 Minimally invasive in vivo flow
cytometry (IVFC) methods have recently garnered significant
interest since they do not require drawing peripheral blood sam-
ples and therefore allow continuous enumeration of cells and
quantification of circulation kinetics in vivo. Although fluores-
cence microscopy, two-photon microscopy, photoacoustic and
photothermal sensing variations of IVFC have been reported
in the literature,
5–8 in general, existing techniques rely on inter-
rogation of relatively small blood vessels with low blood flow
rates on the order of ∼1 to 5 μL∕min (although systems that
rely on interrogation of larger blood vessels have also been
reported).9 This sets a practical lower limit of sensitivity in
the range of 103 cells∕mL, which is often inadequate for
applications where very rare circulating cell populations are
of interest, for example, in the study of early-stage circulating
tumor cells. As such, higher sensitivity IVFC instruments are
needed.
Motivated by this, we recently developed and reported a
new method termed “diffuse fluorescence flow cytometry”
(DFFC).
10,11 The underlying principle was to utilize mesoscopic
scale illumination and detection of fluorescent light from rela-
tively large blood vessels in a limb (e.g., hindleg or tail),10,11
where blood flow rates are about 0.2 to 0.5 mL∕min.12
In principle, this enables sampling of the entire ∼2m Lmouse
blood volume in minutes. Our previously reported design10,11
used two sequentially illuminated lasers and an array of six
detectors arranged in a ring around a mouse limb. As labeled
cells passed through the DFFC field of view, transient fluores-
cence “spikes” were recorded on a multichannel photomultiplier
tube (PMT). We showed that we could detect and coarsely
tomographically localize circulating multiple myeloma (MM)
cells in the tails of nude mice at injected concentrations of
approximately 105 cells∕mL.
Although our previous work provided proof-of-principle
demonstration of the approach, DFFC scanning of the mouse
tail was not optimal because of its dense connective tissue
and correspondingly high optical attenuation. Our data indicated
that we could significantly improve DFFC detection sensitivity
simply by interrogating the hindleg of a mouse since it is sig-
nificantly less attenuating (we estimated by approximately a fac-
tor of 2). However, in practice, when we performed DFFC on
the hindleg, we observed significant movement artifacts due to
breathing and twitching, even in a properly anesthetized animal
with a physically secured leg (versus the tail which could be
more easily immobilized). These motion artifacts had similar
amplitude and temporal characteristics as fluorescent spikes
from cells. As such, they periodically obscured cell spikes or
generated false-positive counts that could not be directly sub-
tracted or filtered out in postprocessing.
In this work, we developed a new multiwavelength DFFC
prototype that, as we show, allowed efficient rejection of move-
ment artifacts, thereby suppressing false-positive cell counts and
allowing us to improve sensitivity by taking advantage of lower
attenuation of the tissue in the mouse hindleg. As we describe in
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and instrument preamplifier performance. In combination, this
allowed detection of individual circulating cells at injected
concentrations of less than 5 × 103 cells∕mL, with an overall
estimated instrument sensitivity on the order of 1 cell∕mL
of circulating peripheral blood or better. This represents at
least an order-of-magnitude improvement versus our previous
work. In this paper, we demonstrate this first in limb-mimicking
optical flow phantoms with fluorescent microspheres and then
in detection and quantification of very low concentrations of cir-
culating Vybrant DiD-labeled mesenchymal stem cells (MSCs)
in nude mice. We anticipate that the high sensitivity of our
DFFC instrument will have many potential applications in pre-
clinical research where very rare circulating cell populations
are of interest.
2 Methods
2.1 DFFC Instrument
A schematic diagram of the dual-wavelength DFFC prototype is
shown in Fig. 1(a). The hindleg of the mouse was illuminated
with two 635 nm diode lasers (Coherent Inc, Santa Clara, CA),
each with a 1-mm spot size and 5-mW intensity. Emitted
fluorescent and autofluorescent light were collected with a
25-mm focal length plano-convex lens (Edmund Optics,
Barrington, NJ) and then separated with a 750-nm dichroic
beamsplitter (Edmund) into two detection arms fitted with either
a 700- or 800-nm bandpass filter (20-nm bandpass, Chroma
Technologies, Bellows Falls, VT) corresponding to “in-band”
and “out-of-band” signals. After filtering, light was focused
onto two single-anode PMTs (H5783-20, Hamamatsu Photonics,
Bridgewater, NJ). As indicated in Fig. 1(b), the 800-nm filter
also passed a small amount of the fluorescence tail of the
Vybrant-DiD fluorophore (used in our in vivo experiments;
see below) so that the ratio of DiD fluorescence in the 800-nm
channel was about 7% of that in the 700 nm channel. The
excitation laser and detection filter wavelengths were selected to
work well with a number of other commonly used fluorophores
including Alexafluor-680 and Cyanine5.5 as well as red-shifted
fluorescent proteins (RFPs) including TurboRFP or mCherry.
13
The output of each PMT was passed through a current pre-
amplifier configured to operate with a 0.1 to 100 Hz spectral
filter (SR570, Stanford Research Systems, Sunnyvale, CA) cor-
responding to the known frequency range of the fluorescent
spikes established in our previous work.
10,11 The gain of the pre-
amplifier was configurable but was typically operated in the 60 to
80 dB range (higher gains were used for in vivo studies). Data
was acquired andprocessedusing custom-writtenMATLABsoft-
ware (The Mathworks, Natick, MA) and a multipurpose data
acquisition system (DAQ, USB-6212, National Instruments,
Austin, TX). Sensitivity of the instrument was also improved
by removal of the DC signal component at the preamplifier
stage. In our previous work, we showed that the magnitude of
the DC component of the detected signal was about 100 times
larger than the detected fluorescent spikes in vivo (due to tissue
and instrument autofluorescence). Therefore, removal of the DC
component allowed us to apply high amplifier gain and increase
theamplitudeofthedetectedspikeswithoutsaturatingthe 10 V
input of our DAQ. Finally, use of open optics, as opposed to
fiber-optic light collection, allowed improvement in geometrical
collection efficiency of our system.
2.2 Phantom Measurements
As an initial test of our prototype instrument and motion artifact
removal algorithm, we used an optical flow phantom model with
similar size, optical properties, and flow speeds as a mouse limb,
as documented in detail in our previous work.10,11 Briefly, these
were 3-mm diameter cylindrical phantoms constructed from
polyester resin (Casting Craft, Fields Landing, CA) with tita-
nium oxide (TiO2, Sigma-Aldrich, Inc., St. Louis, MO) and
ink added to adjust the optical properties which were as follows:
reduced scattering coefficient μ0
s ¼ 50 cm−1 and absorption
coefficient μa ¼ 0.1 cm−1. These optical properties were esti-
mated based on previously published time-resolved charac-
terizations of the phantoms at 730 nm (Ref. 14), which were
assumed to be a good estimate of the optical properties over
the 635- to 800-nm wavelength range used in these experiments.
Solutions of fluorescent microspheres (6 μm PeakFlow Claret,
P-24670, Invitrogen, Carlsbad, CA) having 650 and 690 nm
excitation and emission maxima, respectively, were suspended
in phosphate-buffered saline (PBS) and passed through the
phantom by connecting the embedded 250 μm internal diameter
strand of Tygon tubing (TGY-010-C, Small Parts, Inc., Seattle,
WA) to a microsyringe pump (70-2209, Harvard Apparatus,
Holliston, MA). To simulate limb movement, phantoms were
mounted on a motorized linear translation stage (X-slide,
Velmex, Bloomfield, NY) which could move the phantom
laterally in a sinusoidal pattern. We tested our system under a
variety of physiologically relevant flow speeds (0.5 to 5c m ∕s),
sphere concentrations (103 to 105 spheres∕mL), oscillation
Fig. 1 (a) Schematic of the dual channel DFFC prototype.
(b) Normalized absorption (blue) and emission (red) spectra of
Vybrant-DiD fluorophore. The wavelength range of the laser (blue
line, 635 nm) and two emission filters (red rectangles, 700 and
800 nm) are indicated.
Journal of Biomedical Optics 077002-2 July 2013 • Vol. 18(7)
Pestana et al.: Improved diffuse fluorescence flow cytometer prototype for high sensitivity detection...frequencies (1 to 3 Hz) and oscillation amplitudes (1 to 5 mm).
These frequency ranges were chosen since they approximately
match breathing artifacts in mice observed in our previous work
and by other groups.
10,11,15
We also tested the signal-to-noise ratio (SNR) improvement
realized through the use of the 0.1 Hz high-pass filter and
increased preamplification with four additional phantoms. For
these experiments, microsphere concentrations of 103∕mL
and flow speeds of 1c m ∕s were used, and we did not move
the translation stage as above to isolate the improvement
realized by the filter. We use the standard definition of
SNR ¼ 20 · logðIs∕σbÞ, where Is is the mean spike height
in the trace and σb is the standard deviation of the back-
ground noise.
Finally, we tested the SNR improvement obtained using open
optic collection of fluorescent light, as opposed to fiber optic
collection as in our previous prototype.
10,11 We used a 1-m
long multimode, 0.37 NA, 600 μm core step-index optical fiber
(BFL37-600; Thorlabs, Newton, NJ), the output of which was
coupled to a PMT using an sub miniature version A (SMA)-
coupled achromatic plano-convex lens package (F260 SMA-
B; Thorlabs). As in our previous work, we used two 700-nm
bandpass filters, (30 nm BP, Edmund Optics) placed between
the fiber and the sample and between the fiber output and
the PMT. The fiber was positioned as close to the phantom
as possible (∼5m m ) to maximize light collection. SNR was
measured for the open optic and fiber optic configurations
for an additional four phantoms with 103 microspheres∕mL at
a flow rate of 1c m ∕s.
2.3 In Vivo Testing of the DFFC
We tested our system in vivo with nude (nu∕nu) mice injected
with MSCs. Before injection, suspensions of MSCs were
incubated for 30 min at 37°C with 0.1 mM DiD (Molecular
Probes, Eugene, OR) and washed three times to remove excess
dye. Mice were anesthetized using a cocktail of ketamine
(100 mg∕kg) and xylazine (5m g ∕kg) and a total of 1 × 104
labeled MSCs suspended in 100 μL of media were injected
via the tail vein (N ¼ 3), leading to approximately
5 × 103 cells∕mL initially in circulation in the ∼2m Lblood
volume. Uninjected (N ¼ 4) mice served as controls. MSCs
were observed to take up DiD by approximately a factor of 2
compared to MM cells as we used in our previous studies.
10,11
Micewere placedon an adjustableplatform in front of the DFFC
with a warming pad. The back leg was positioned under the
detector and carefully secured to a holder with medical adhesive
tape to limit breathing movement as much as possible. The
lower section of the mouse leg (approximately 3 mm in diam-
eter) was placed in the DFFC field of view. Illumination with
two lasers on opposite sides of the limb generated a symmetrical
but nonuniform fluence profile in the cross-section, which may
have resulted in minor differences in sensitivity at different axial
positions. Approximately 5 to 10 min passed between the time
of injection and DFFC data collection, and data was acquired for
at least 30 min in each case.
2.4 Movement Artifact Correction
Movement artifacts were removed from the fluorescence traces
using
IflðtÞ¼I700ðtÞ − αI800ðtÞ; (1)
where IflðtÞ is the corrected fluorescence trace, and I700ðtÞ and
I800ðtÞ were measured signals at 700 and 800 nm, respectively.
The scalar α reflected the inherent relative autofluorescence
intensities at 700 and 800 nm as well as differences in detec-
tion efficiency (optical throughput, detector sensitivity, etc.).
Accurate estimation of this parameter was critical to the
approach. Initially, we attempted to simply measure the mean
value of the ratio of the two traces for a control (uninjected)
mouse. However, it was determined experimentally that this
value varied by as much as 300% between individual animals.
A more robust method was to estimate α for individual mice
using the ratio of the variances of the two signals,
α ¼ σ2
I−700∕σ2
I−800. (2)
Here, a fixed percentage of measured data points with great-
est deviation from mean was excluded from the variance calcu-
lation. The rationale was that the points with the largest
deviation may contain signals from circulating cells and thus
should be excluded from estimation of α. As we describe below,
it was experimentally determined using phantom models that
rejection of about 50% of the data set resulted in stable estima-
tion of α at cell concentrations in the range of 103 to 104∕mL
which corresponds to the expected operating range of our sys-
tem in vivo.
2.5 Fluorescence Microscopy In Vivo Flow
Cytometry
We also performed fluorescence microscopy IVFC on severe
combined immunodeficiency (SCID) mice in parallel (as has
been described in detail previously)5 to compare and validate
the MSC clearance kinetics measured with the DFFC prototype.
Briefly, three mice were anesthetized with inhaled isofluorane
and 106 MSC Vybrant-DiD-labeled cells (using the same label-
ing protocol as above) were injected intravenously. Mice were
positioned on a temperature-controlled stage (32°C). An appro-
priate arteriole in the ear was then chosen for obtaining measure-
ments. Fluorescence from DiD-labeled cells was excited with
a 633-nm HeNe laser (1144P, JDS Uniphase, Milpitas, Ca)
focused acrossthe arteriole and fluorescence signal was detected
by a PMT (R3896 with socket C6271, Hamamatsu Corporation,
Bridgewater, NJ) through a 670   20-nm filter (XF3030
670DF40, Omega Optical, Brattleboro, VT). The output of the
PMTwas digitized for analysis on a personal computer equipped
with MATLAB software (The MathWorks) and cell counts per
minute following injection are obtained. The time between injec-
tion and beginning of IVFC measurements was about 3 min.
3 Results and Discussion
3.1 Phantom Experiments
We first tested our system with phantoms mounted on a
motorized linear translation stage. Example data is shown in
Fig. 2(a)–2(d), where solutions of 103 microspheres∕mL were
flowed through a phantom at 1c m ∕s. In this case, the phantom
was movedlaterally in a sinusoidal pattern with 2 mm amplitude
(representing a large movement artifact effect) at a frequency of
1.8 Hz. Data traces acquired at 700 and 800 nm are shown in
Fig. 2(a) and 2(b), respectively. In Fig. 2(b), the 800 nm signal
was scaled by α (in this case about 2.5), reflecting the relative
sensitivity and autofluorescence intensity between the two chan-
nels (minimal fluorescence bleed was observed in the 800-nm
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than Vybrant-DiD). As is evident, sinusoidal movement artifacts
almost completely obscured some fluorescent spikes from
microspheres in the 700 nm trace (red arrows). We then applied
our movement correction algorithm and the results are plotted in
Fig. 2(c), wherein the individual fluorescence spikes were
significantlymoreapparent. In the specific example in Fig. 2(a)–
2(c), the average spike SNR was increased from 21.8 to
28.1 dB, with an average SNR improvement of approximately
6 dB over all phantoms tested. As a further check, we applied
a 1.8-Hz notch filter directly to the 700 nm data and replotted
the data in Fig. 2(d). Excellent agreement between the
two traces was observed, demonstrating the efficacy of the
movement artifact rejection approach. It is noted, however,
that this type of simple signal filtering of movement artifacts
is not possible in mice in vivo since the frequency of movement
artifacts exhibits strong inter- and intraexperimental variability
and overlaps with detected spikes.
Further SNR improvement was gained from the use of a high
pass (0.1 Hz) preamplifier filter, which allowed greater ampli-
fication of the PMT output without saturating the  10 V input
limit of our DAQ board. Example data acquired with and with-
out the high-pass filter in operation are shown in Fig. 2(e) and
2(f), respectively. On average, use of the high-pass filter
improved the SNR from 23.2   2.7 dB to 27.2   2.1 dB
(i.e., approximately 4 dB) over the phantoms tested. Likewise,
we quantified the improvement in SNR obtained using open-
optic versus fiber-optic collection of fluorescent light as shown
in Fig. 2(g) and 2(h), respectively. On average, the SNR with
fiber collection was 20.4   2.2 dB compared with 27.8 
3.0 dB with open optics for the phantoms tested, yielding an
average improvement of approximately 7 dB. We note that in
Fig. 2 Example data trace acquired at 700 nm (a) from a flow phantom with 103 microspheres∕mL, physically moved at 1.8 Hz with 2 mm amplitude.
The effects of movement artifacts are evident as they obscure fluorescent spikes from the microspheres. (b) the background signal acquired at 800 nm
scaled by weighting factor α (see text for details), (c) weighted subtraction of the out-of-band signals allowed effective removal of the movement
artifacts, allowing better visualization of spikes, and (d) replotting the 700 nm data trace with a 1.8 Hz-bandpass filter applied in post-processing,
demonstrating the accuracy of the motion artifact removal approach. Example data acquired (e) with and (f) without the 0.1 Hz high-pass filter in
operation. Removing the DC component of the signal allowed us to increase amplification, increasing the average SNR by approximately 4 dB.
Example data acquired from a phantom (g) with open optics setup as shown in Fig. 1(a), and (h) with fiber-optic light collection similar to our previous
design (Refs. 10, 11), increasing the SNR by approximately 7 dB.
Journal of Biomedical Optics 077002-4 July 2013 • Vol. 18(7)
Pestana et al.: Improved diffuse fluorescence flow cytometer prototype for high sensitivity detection...our previous work,
10,11 we used an array of six detector fibers to
improve this SNR (and summed the signal from the six chan-
nels); as such we intend to use at least four detector arms [as in
Fig. 1(a)] in DFFC future prototypes to further increase collec-
tion efficiency.
For phantom experiments, it was possible to directly calcu-
late the ratio α [as in Eq. (1)] by first running a blank solution of
PBS through the phantom. However, when operating the DFFC
in vivo, this is not generally possible since cells are frequently
injected prior to scanning. Therefore, to estimate α when
fluorescent microspheres were present in the signal, we flowed
dilutions of spheres through phantoms at 103, 104,o r
105 spheres∕mL. As shown in Fig. 3, we excluded a fixed
percentage of points with the largest deviation from the calcu-
lation and compared this to the “true” value of α, which was
obtained by flowing PBS through the phantom. Exclusion of
∼50% of the outliers resulted in negligible error in the estimated
value for α for our target DFFC operating range of 103 and
104 spheres∕mL. At higher concentrations (105 spheres∕mL),
α was overestimated by about 50% when half of the signal
was excluded due to the large fraction of time that spheres
were in the DFFC field-of-view. Although this implies an
upper limit of DFFC operation in vivo (without additional
processing), we note that, in practice, this effect would lead
to overestimation of α which would reduce the amplitude of
detected spikes. This is preferable to underestimation which
might produce false-positive cell counts. Further, this error
is actually significantly smaller than observed when using a
separate uninjected control animal to estimate α.
3.2 In Vivo Experiments
Example data from the in vivo experiments are shown in
Fig. 4(a)–4(i). Example traces acquired at 700 nm are shown
for two injected and one uninjected control mouse in
Fig. 4(a), 4(d) and 4(g), respectively. Although mice were prop-
erly anesthetized and the hindleg restrained, significant move-
ment artifacts were observed in the control data [Fig. 4(g)]
which, by simple inspection, were difficult or impossible to
Fig. 4 Exampledata acquiredfrom the hindlegof (a–f) nudemice injectedwith 104 Vybrant-DiDlabeledMSCs, and (g–i) uninjectedcontrol mice.As is
evident from the data acquired at 700 nm (a, d, g) movement artifacts were problematic since they obscured cells and potentially introduced false-
positive counts in control mice. (b, e, h) Background signals were acquired at 800 nm and then scaled by the weighting factor α. (c, f, i) Weighted
subtraction was performed, significantly reducing movement artifacts. After rescaling, emission from the Vybrant DiD fluorophore in the 800-nm
channel reduced the corrected spike heights, an effect that was also observed when we tested (j–l) optical flow phantoms with fluorescently labeled
MSCs. The(j) fluorescence signal, (k)scaled background signal,and (l) correctedsignalare shown.Dottedlines in panels(c, f, g, l)indicatethe counting
threshold for each sample.
Fig. 3 Estimation of α from phantoms with (a) 103, (b) 104 and
(c) 105 microspheres∕mL, respectively, with fixed fractions of data
points with highest deviation from the mean removed from the calcu-
lation. The dotted line represents the selected threshold which allowed
stable estimation of α for sphere concentrations below 104∕mL.
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Movement correction was performed by weighted subtraction
of data acquired at 800 nm shown in Fig. 4(b), 4(e), and 4
(h); as above, the 800 nm traces presented were scaled by α.
In general, α varied significantly between individual animals
and for the subset of data in Fig. 4 ranged from 3.1 to 10.0.
The corresponding background-subtracted data were then
replotted in Fig. 4(c), 4(f), and 4(i). In all experiments per-
formed, this operation suppressed motion artifacts in control
mice [Fig. 4(i)], while substantial residual fluorescence, i.e.,
fluorescent “spikes,” were observed in injected mice [Fig. 4(c)
and 4(f)]. However, significant bleed from the Vybrant-DiD
fluorescent tail was observed in the 800-nm channel [i.e., in
Fig. 4(b) and 4(e)] which, when weighted by α, reduced the
overall spike height by approximately 40% to 75% [Fig. 4(c)
and 4(f)] depending on the ratio of the background autofluor-
escence between the two channels (i.e., larger values of α
resulted in a greater effect). Similar reduction was observed
when we tested Vybrant-DiD-labeled MSCs in optical flow
phantoms as shown in Fig. 4(j)–4(l). In this phantom, α was
4.8 and spike heights were reduced on average by about
45%. Unlike in phantoms, the average SNR of detected spikes
measured in vivo before and after motion artifact correction was
comparable (14.5   3.9 dB pre versus 14.0   3.0 dB), pri-
marily due to the issue of bleed into the 800-nm background
channel and associated reduction of spike height. We expect
that better selection of detection filters and fluorophores can
mitigate or eliminate this problem in the future and as a result
further improve the system SNR. Despite this issue, we were
able to measure clear spikes in vivo following background sub-
traction in the injected mice we tested, and motion artifacts were
effectively suppressed in control mice.
Moreover, cells could be enumerated with this technique as
follows: We counted any detected spikes above a minimum
threshold equal to four times the standard deviation above
baseline as a cell. This threshold is indicated by the dotted
lines in Fig. 4(c), 4(f), and 4(i) for these specific mice, but
this threshold varied significantly between individual animals
depending on background noise. Using this definition, the
motion artifact rejection algorithm reduced the false-positive
rate in control (uninjected) mice on average by a factor of 3,
from 0.18 false positives∕min to 0.06∕min (the latter value
being in reasonable agreement with the expected false-positive
rate of 0.02∕min based on the 4σ threshold and assuming
normally disturbed data acquired at 600 data samples∕min).
Therefore, this significant reduction in false-positive cell counts
allowed us to take an advantage from the lower optical attenu-
ation of the hindleg (which we estimate was approximately
half that of the tail) and resulted in improved instrument
sensitivity.
Example clearance data for MSCs measured with the DFFC
is shown in Fig. 5 (red line), showing the normalized cell count
rate as a function of time (there were approximately 5 to 10 min
between injection and start of data acquisition). The error bars
shown are the standard error from three repeated experimental
trials. As a comparison, the clearance kinetics of 106 injected
MSC cells in SCID mice was measured using fluorescence
microscopy IVFC,
5 and the data is also shown in Fig. 5
(blue line). These experiments were performed in parallel on
different mice, but nonetheless allow comparison of clearance
kinetics measured by the two systems. We normalized the
data in Fig. 5 to the first measurement time point for both
instruments since the exact time from injection to start of the
acquisition was slightly different in both cases and since signifi-
cantly different concentrations of cells were injected. Generally,
the kinetics agreed well, indicating a cell clearance half-life of
about 10 min although slightly faster clearance was measured
with the DFFC system in nude mice. This disagreement may
have been due to the use of different mouse strains or dilutions
of MSCs between experiments. Since IVFC is a well-character-
ized approach, this demonstrates the ability of the DFFC to
quantitatively measure rapid changes in cell populations in vivo.
Finally, we could estimate the overall sensitivity of our
DFFC prototype as follows: of the injected cell concentration
of 5 × 10 cells∕mL, our flow cytometry analysis of drawn
peripheral blood samples indicates that between 1% and 10%
remained in circulation 5 min following injection (unpublished
data) since many of the MSCs are trapped at the site of injection
as well as in the lung and spleen as the initial injected bolus of
cells passes through the animal. Therefore, the true concentra-
tion of circulating cells is not known but was most likely in the
range of 50 to 500 cells∕mL. At this concentration, our mea-
sured maximum cell count rate (i.e., at the first time point
in Fig. 5) was 6.0   2 cells∕min. Therefore, assuming a 1-h
acquisition, the minimum sensitivity would be in the range
of 0.14 to 1.4 cells∕mL. Given that the DFFC system has a
false-positive rate of 0.06∕min (after correction), we can esti-
mate that our system has detection sensitivity on the order
of 1 cell∕mL.
In conclusion, these data demonstrate the high detection sen-
sitivity of our new DFFC prototype compared to our previous
work.10,11 We previously performed DFFC scanning in the
mouse tail since it could be easily immobilized, but detection
sensitivity suffered due to the dense, optically attenuating con-
nective tissue. As such, the improved sensitivity shown in this
work resulted from the lower optical attenuation of the hindleg
and an efficientrejection of movementartifacts. This was impor-
tant since movement artifacts created a relativelyhigh number of
false-positive counts (i.e., 0.18∕min) relative to true counts
(∼6 counts∕min at maximum in these studies). Filtering of
the DC component of the PMT output also allowed us to better
amplify the detected fluorescent spikes without saturating the
input of our DAQ board, which further improved sensitivity.
Fig. 5 Example data showing clearance of MSCs from circulation after
injection. Normalized cell counts acquired with the DFFC for 104 cells
injected are shown, along with normalized cell counts acquired using
IVFC in SCID mice injected with 106 cells for comparison. Both meth-
ods yielded a circulation half-life of about 10 min.
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opposed to fiber optic collection) improved collection efficiency
and the overall sensitivity of the instrument. Compared to our
previous prototype,
10,11 we also used larger single element
PMTs (with ∼50 mm active detector area) versus a multianode
PMT (with ∼6m m 2 detector area per anode). Both PMTs had
similar quantum efficiency in this spectral range. Although we
did not test this directly, the larger PMT active area may have
further increased SNR. We also recorded the amplified analog
output of the PMT in the current prototype as opposed to per-
forming photon counting as we did previously.
Optimization of detection optics to reduce or eliminate fluo-
rophore bleed into the background detection channel is a priority
in future prototypes. We also plan to test our system with alter-
nate cell lines and mouse models. Our choice of excitation laser
and emission filters for this prototype will allow us to use the
technique for a range of immunotargeted organic near-infrared
fluorophores or constitutively expressed fluorescent proteins for
the long-term study of a number of biological models.
16 In par-
ticular, we anticipate that this technique has significant potential
use in applications where very rare circulating cell populations
are of interest, such as study of early-stage metastatic develop-
ment or dissemination of hematological malignancies in small
animals. Moreover, as we have documented in our earlier work,
it is also possible that individual cells could be over-counted if
they passed through the DFFC field-of-view multiple times in
the vasculature. Therefore, in the future, we also plan to add
tomographic imaging capabilities to this system as we have
done previously
10 through modulation of the sources and the
addition of multiple detector arms.
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